Cargando…

Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region

Islet transplantation is considered a potential therapeutic option to reverse diabetes. The pancreatic basement membrane contains a variety of extracellular matrix (ECM) proteins. The abundant ECM is essential for the survival of transplanted islets. However, the ECM proteins necessary for maintaini...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qunyan, Lu, Cuitao, Jiang, Xuan, Yao, Qing, Jiang, Xue, Huang, Zhiwei, Jiang, Yina, Peng, Lei, Fu, Hongxing, Zhao, Yingzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965329/
https://www.ncbi.nlm.nih.gov/pubmed/31998133
http://dx.doi.org/10.3389/fphar.2019.01536
_version_ 1783488618666393600
author Zhu, Qunyan
Lu, Cuitao
Jiang, Xuan
Yao, Qing
Jiang, Xue
Huang, Zhiwei
Jiang, Yina
Peng, Lei
Fu, Hongxing
Zhao, Yingzheng
author_facet Zhu, Qunyan
Lu, Cuitao
Jiang, Xuan
Yao, Qing
Jiang, Xue
Huang, Zhiwei
Jiang, Yina
Peng, Lei
Fu, Hongxing
Zhao, Yingzheng
author_sort Zhu, Qunyan
collection PubMed
description Islet transplantation is considered a potential therapeutic option to reverse diabetes. The pancreatic basement membrane contains a variety of extracellular matrix (ECM) proteins. The abundant ECM is essential for the survival of transplanted islets. However, the ECM proteins necessary for maintaining islet vascularization and innervation are impaired by enzymatic digestion in the isolation process before islet transplantation, leading to destruction of islet microvessels. These are the primary concern and major barrier for long-term islet survival and function. Thus, it is crucial to create an appropriate microenvironment for improving revascularization and islet function to achieve better transplantation outcome. Given the importance of the presence of ECM proteins for islets, we introduce recombinant human collagen (RHC) to construct a simulated ECM microenvironment. To accelerate revascularization and reduce islet injury, we add basic fibroblast growth factor (bFGF) to RHC, a growth factor that has been shown to promote angiogenesis. In order to verify the outcome, islets were treated with RHC combination containing bFGF and then implanted into kidney capsule in type 1 diabetic mouse models. After transplantation, 30-day-long monitoring displayed that 16 mg–60 ng RHC-bFGF group could serve as superior transplantation outcome. It reversed the hyperglycemia condition in host rapidly, and the OGTT (oral glucose tolerance test) showed a similar pattern with the control group. Histological assessment showed that 16 mg–60 ng RHC-bFGF group attenuated apoptosis, promoted cellular proliferation, triggered vascularization, and inhibited inflammation reaction. In summary, this work demonstrates that application of 16 mg–60 ng RHC-bFGF and islets composite enhance the islet survival, function, and long-term transplantation efficiency.
format Online
Article
Text
id pubmed-6965329
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69653292020-01-29 Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region Zhu, Qunyan Lu, Cuitao Jiang, Xuan Yao, Qing Jiang, Xue Huang, Zhiwei Jiang, Yina Peng, Lei Fu, Hongxing Zhao, Yingzheng Front Pharmacol Pharmacology Islet transplantation is considered a potential therapeutic option to reverse diabetes. The pancreatic basement membrane contains a variety of extracellular matrix (ECM) proteins. The abundant ECM is essential for the survival of transplanted islets. However, the ECM proteins necessary for maintaining islet vascularization and innervation are impaired by enzymatic digestion in the isolation process before islet transplantation, leading to destruction of islet microvessels. These are the primary concern and major barrier for long-term islet survival and function. Thus, it is crucial to create an appropriate microenvironment for improving revascularization and islet function to achieve better transplantation outcome. Given the importance of the presence of ECM proteins for islets, we introduce recombinant human collagen (RHC) to construct a simulated ECM microenvironment. To accelerate revascularization and reduce islet injury, we add basic fibroblast growth factor (bFGF) to RHC, a growth factor that has been shown to promote angiogenesis. In order to verify the outcome, islets were treated with RHC combination containing bFGF and then implanted into kidney capsule in type 1 diabetic mouse models. After transplantation, 30-day-long monitoring displayed that 16 mg–60 ng RHC-bFGF group could serve as superior transplantation outcome. It reversed the hyperglycemia condition in host rapidly, and the OGTT (oral glucose tolerance test) showed a similar pattern with the control group. Histological assessment showed that 16 mg–60 ng RHC-bFGF group attenuated apoptosis, promoted cellular proliferation, triggered vascularization, and inhibited inflammation reaction. In summary, this work demonstrates that application of 16 mg–60 ng RHC-bFGF and islets composite enhance the islet survival, function, and long-term transplantation efficiency. Frontiers Media S.A. 2020-01-10 /pmc/articles/PMC6965329/ /pubmed/31998133 http://dx.doi.org/10.3389/fphar.2019.01536 Text en Copyright © 2020 Zhu, Lu, Jiang, Yao, Jiang, Huang, Jiang, Peng, Fu and Zhao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhu, Qunyan
Lu, Cuitao
Jiang, Xuan
Yao, Qing
Jiang, Xue
Huang, Zhiwei
Jiang, Yina
Peng, Lei
Fu, Hongxing
Zhao, Yingzheng
Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region
title Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region
title_full Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region
title_fullStr Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region
title_full_unstemmed Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region
title_short Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region
title_sort using recombinant human collagen with basic fibroblast growth factor to provide a simulated extracellular matrix microenvironment for the revascularization and attachment of islets to the transplantation region
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965329/
https://www.ncbi.nlm.nih.gov/pubmed/31998133
http://dx.doi.org/10.3389/fphar.2019.01536
work_keys_str_mv AT zhuqunyan usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT lucuitao usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT jiangxuan usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT yaoqing usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT jiangxue usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT huangzhiwei usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT jiangyina usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT penglei usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT fuhongxing usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion
AT zhaoyingzheng usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion